CDVCA and New Orleans BioFund co-invest to advance bioscience innovation and economic opportunity in New Orleans

The Community Development Venture Capital Alliance (CDVCA) and the New Orleans BioFund, part of the New Orleans BioInnovation Center (NOBIC), have both invested in two bioscience companies expanding operations in New Orleans neighborhoods where impact capital can make an outsized difference.

The two venture funds co-invested in the seed round of Informuta, an AI-powered infectious disease diagnostics company focused on addressing antibiotic resistance and improving treatment outcomes for patients with healthcare-associated infections (HAIs). The investment will support Informuta's expansion into communities facing persistent health and economic inequities, advancing both public health innovation and local economic development.

CDVCA and the New Orleans BioFund also co-invested in the pre-seed round of Beken Bio, a biotechnology company developing a blood-based diagnostic test designed to detect early signs of ovarian cancer, one of the deadliest cancers due to late-stage diagnosis. The investment in Beken Bio will help finance development of a CLIA-certified laboratory in New Orleans and advance the company's diagnostic platform to enable detection of additional cancers, including lung, colorectal and pancreatic cancers. Both investments are expanding the New Orleans economy and creating jobs.

To read the full press release on these two investments, click here.